Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

British Journal of Pharmacology
E J LewisK Wilson

Abstract

1. Ro 32-3555 (3(R)-(cyclopentylmethyl)-2(R)-[(3,4,4-trimethyl-2,5-dioxo-1- imidazolidinyl)methyl]-4-oxo-4-piperidinobutyrohydroxamic acid) is a potent, competitive inhibitor of human collagenases 1, 2 and 3 (Ki values of 3.0, 4.4 and 3.4 nM, respectively). The compound is a selective inhibitor of collagenases over the related human matrix metalloproteinases stromelysin 1, and gelatinases A and B (Ki values of 527, 154 and 59 nM, respectively). 2. Ro 32-3555 inhibited interleukin-1 alpha (IL-1 alpha)-induced cartilage collagen degradation in vitro in bovine nasal cartilage explants (IC50 = 60 nM). 3. Ro 32-3555 was well absorbed in rats when administered orally. Systemic exposure was dose related, with an oral bioavailability of 26% at a dose of 25 mg kg-1. 4. Ro 32-3555 prevented granuloma-induced degradation of bovine nasal cartilage cylinders implanted subcutaneously into rats (ED50 = 10 mg kg-1, twice daily, p.o.). 5. Ro 32-3555 dosed once daily for 14 days at 50 mg kg-1, p.o., inhibited degradation of articular cartilage in a rat monoarthritis model induced by an intra-articular injection of Propionibacterium acnes. 6. Ro 32-3555 is a potential therapy for the treatment of the chronic destruction of articulating cartilage ...Continue Reading

References

Sep 1, 1991·Arthritis and Rheumatism·C E Brinckerhoff
Nov 1, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·K C Ho, C P Pang
Jan 1, 1987·Journal of Enzyme Inhibition·W H JohnsonN Borkakoti
Sep 9, 1986·Biochemistry·W M Moore, C A Spilburg
Apr 7, 1987·Biochemistry·K A MookhtiarH E Van Wart
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·E R PettipherB Henderson
May 1, 1974·Arthritis and Rheumatism·S M Krane
May 1, 1980·Analytical Biochemistry·B Johnson-Wint
Jan 1, 1995·Methods in Enzymology·M DioszegiH E Van Wart
Sep 1, 1993·Journal of Pharmacological and Toxicological Methods·J BishopE J Lewis
Dec 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·W G Stetler-StevensonD E Kleiner
Jan 1, 1993·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·H Birkedal-HansenJ A Engler

❮ Previous
Next ❯

Citations

Jan 31, 2002·Arthritis and Rheumatism·John A MengsholConstance E Brinckerhoff
Nov 17, 2009·Cell and Tissue Research·Tim E Cawston, David A Young
Mar 5, 1999·Breast Cancer Research and Treatment·P D Brown
Jul 1, 2008·Nature Biotechnology·Yukihiko AikawaShunichi Shiozawa
May 18, 1999·Current Opinion in Rheumatology·U Müller-LadnerS Gay
Apr 23, 2003·Current Opinion in Rheumatology·Edward C Keystone
Jul 23, 1999·Annals of the New York Academy of Sciences·J F Woessner
Jan 13, 2001·Annals of the Rheumatic Diseases·S ElliottT E Cawston
Oct 16, 2002·Annals of the Rheumatic Diseases·U Müller-Ladner, S Gay
Nov 16, 2006·Arthritis Research & Therapy·Stefan BauerChristoph Renner
May 1, 2008·Expert Opinion on Drug Discovery·Helmtrud I Roach
Jun 27, 2002·Expert Opinion on Investigational Drugs·Sheila A Doggrell
Nov 4, 2000·Expert Opinion on Investigational Drugs·T ShawK M Bottomley
Nov 4, 2000·Expert Opinion on Investigational Drugs·P D Brown
Oct 28, 1999·Journal of Enzyme Inhibition·P A MarcotteS K Davidsen
Nov 19, 2015·Connective Tissue Research·Annu NäkkiUrho M Kujala
Nov 1, 2011·Bone·Johanne Martel-PelletierJean-Pierre Pelletier
Nov 10, 2010·Journal of Clinical Pharmacology·Cathye ShuDonald Raible
Jan 1, 2014·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Ying Ju ChenShing Hwa Liu
Nov 14, 2006·Pharmacology & Therapeutics·Georgie FearIlya Raskin
Sep 19, 2006·Best Practice & Research. Clinical Rheumatology·Tim E Cawston, Amy J Wilson
Jan 29, 2002·Best Practice & Research. Clinical Rheumatology·J Martel-PelletierJ P Pelletier
Nov 1, 2006·Allergology International : Official Journal of the Japanese Society of Allergology·Masahiro KimataNaoki Inagaki
Oct 27, 2015·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Ying-Ju ChenShing-Hwa Liu
Oct 23, 2008·PloS One·Bénédicte MugnierPierre Ferrier
Aug 20, 2016·Nature Reviews. Rheumatology·William H RobinsonJeremy Sokolove
Mar 11, 2004·Veterinary Immunology and Immunopathology·K J RickardsF M Cunningham
Apr 26, 2017·International Journal of Molecular Sciences·Yasuto Araki, Toshihide Mimura
Feb 24, 2001·Bioorganic & Medicinal Chemistry Letters·A M CholletP Casara
Feb 24, 2001·Bioorganic & Medicinal Chemistry Letters·J I LevinJ S Skotnicki
Sep 25, 2002·Bioorganic & Medicinal Chemistry Letters·Frances C NelsonJ Donald Albright
Jan 31, 2003·Expert Opinion on Therapeutic Targets·Ian M Clark, Andrew E Parker
Nov 13, 2018·Expert Opinion on Emerging Drugs·Win Min OoDavid John Hunter
Jun 18, 1998·Journal of Enzyme Inhibition·K M BottomleyD S Walter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.